Pfizer’s RSV vaccine for older adults, pregnant people approved by Health Canada – National
Descrease article font size Increase article font size Health Canada on Thursday approved another respiratory syncytial virus (RSV) vaccine for adults over the age of 60 and pregnant people. Pfizer’s bivalent RSV vaccine, Abrysvo, has been authorized for the use of pregnant individuals from 32 through 36 weeks gestational age for the prevention of lower respiratory … Read more
